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Introduction: Invasive Aspergillus commonly involves the lungs, but can also affect other organs such as the skin,
adrenal glands, central nervous system, liver, spleen and the gastrointestinal tract. Gastrointestinal aspergillosis is
rare and is most often discovered in immunocompromised patients. There is only one other case report to our
knowledge that describes the diagnosis being discovered on histopathological analysis of endoscopic biopsies of
necrotic ulcers.
Case presentation: A 36-year-old Hispanic woman presented with septic shock secondary to extensive Fournier
gangrene that required multiple surgical debridement of the perineal and retroperitoneal area. Her vital signs on
admission were a temperature of 39.4°C and blood pressure of 85/56mmHg, pulse rate of 108/min and respiratory
rate of 25. An examination of the perineum/genital area revealed bilateral gluteal and perilabial edema, erythema
and focal areas of necrotic tissue with purulent discharge. Other surgeries included small bowel resections with
ileoileal anastomosis that later developed an anastomotic leak that required and diverting end ileostomy. Eleven weeks
after admission, our patient developed hematochezia from the colostomy associated with a decrease in hemoglobin
and hematocrit to 6.4g/dL and 20.2% respectively.
Colonoscopy through the ostomy revealed blood throughout the colon and a 3cm necrotic ulcer with an adherent
clot in the transverse colon. Biopsies were taken from the edge of the ulcer. Histopathological analysis of the specimen
with Grocott’s methenamine silver stain revealed septated hyphae with the 45-degree-angle branching that is
morphologically consistent with Aspergillus species. Our patient was treated with intravenous voriconazole for 30 days
with a prolonged hospitalization but no recurrent bleeding.
Conclusions: Gastrointestinal aspergillosis is an unusual presentation of invasive Aspergillus associated with a high
mortality rate. Characteristic features of gastrointestinal aspergillosis include invasion of the mesenteric arteries,
intravascular thrombosis and subsequent tissue ischemia. Clinical manifestations of invasive Aspergillus of the
gastrointestinal tract can include fever, abdominal pain, ileus, peritonitis, bloody diarrhea or hematochezia. In an
autopsy series of patients with invasive Aspergillus, 37 of 107 patients had Aspergillus involvement of the gastrointestinal
system; the most common pathological findings included ulcers and abscesses. Although rare, invasive aspergillosis
may present with gastrointestinal bleeding associated with necrotic ulcers on endoscopic examination.
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Aspergillus species are ubiquitous saprophytic spore-
producing fungi commonly found in the environment.
Out of its approximately 200 species, Aspergillus fumiga-
tus is responsible for the vast majority of cases of human
invasive aspergillosis, a potentially fatal illness that affects
the lungs and other organs of immunocompromised pa-
tients. Invasive aspergillosis is associated with a 50 to 60%
mortality rate [1,2]. Other potential species include Asper-
gillus niger, Aspergillus flavus and Aspergillus terreus [3].
Human disease usually begins with inhalation or ingestion
of its airborne conidia. These conidia are deposited in the
sinuses, bronchioles and alveoli. In healthy individuals, the
spores that are not removed through mucociliary clea-
rance are eliminated through phagocytosis and a pro-
inflammatory response by alveolar macrophages [4].
Occasionally, conidia may evade destruction by the al-
veolar macrophages. In these cases, neutrophils kill any
remaining pathogens. If the conidia evade the host de-
fenses, they reach the bloodstream and invade the endo-
thelial cell lining of the blood vessels, disseminating to
various organs through a hematogenous route. Therefore,
if a dysfunction exists in the host’s cellular immune sys-
tem, the risk of developing invasive aspergillosis (IA) in-
creases. Neutropenia and corticosteroid use are two of the
most common conditions associated with this scenario.
The lungs are the most common organ affected by IA,
but given its hematogenous spread, other sites, such as
the gastrointestinal tract may also be involved. Aspergillus
spores usually do not survive on the mucosal surfaces of
the gastrointestinal tract. However, it has been proposed
that any mechanism that causes disruption of the gastro-
intestinal mucosa can predispose the bowel to IA.Case presentation
A 36-year-old Hispanic woman presented with severe
perineal pain radiating to the right gluteal area for one
week. Her associated symptoms included fever, chills,
nausea, fatigue and shortness of breath. She denied any
vaginal discharge, dysuria, changes in stool color, bloody
stools, vomiting or diarrhea. No past medical problems
were noted. Her social history was relevant for a long-
standing history of alcohol use and smoking. Her vital
signs on admission revealed a temperature of 39.4°C,
blood pressure of 85/56mmHg, heart rate of 109/min
and respiratory rate of 25/min. A physical examination
revealed rhonchi in both lung fields, no heart murmurs,
and diffuse abdominal tenderness without guarding or
rebound signs. An examination of the perineum/genital
area revealed bilateral gluteal and perilabial edema and
erythema, associated with increased local tempera-
ture and focal areas of necrotic tissue with purulent
discharge.Initial laboratory results upon admission were a white
blood cell count of 6.09 × 103uL, hemoglobin of 17.9g/dL,
hematocrit of 51.8%, platelet count of 53 × 103/uL, blood
urea nitrogen of 32mg/dL, creatinine of 1.77mg/Dl and
serum glucose of 196mg/dL. A computed tomography
(CT) scan of the abdomen and pelvis revealed extensive
necrotizing fasciitis at the right gluteal region extending
into the pelvis, retroperitoneal space and the anterior ab-
dominal wall. The posterior and medial compartments of
the right thigh were also involved. Our patient was admit-
ted to the surgical intensive care unit with a diagnosis of
septic shock secondary to Fournier’s gangrene. The first
surgery was surgical debridement of the right perineum,
perirectal ischioanal and gluteus region. Additional surgi-
cal procedures included exploratory laparotomy, debride-
ment of retroperitoneum and bilateral anterior abdominal
wall and drainage of pelvic abscesses. She had multiple ex-
plorations of the abdomen and perineal area with debride-
ment of necrotic tissue. She later developed a small bowel
perforation of the ileum resulting in fecal peritonitis. She
therefore had a small bowel resection with ileoileal anasto-
mosis. One week later, she developed an anastomotic leak
that required resection of the anastomosis and creation of
an end ileostomy. Our patient subsequently developed
pancreatic necrosis with abscess formation requiring
exploratory laparotomy for drainage of the abscess and de-
bridement of pancreatic necrosis. Eight weeks after admis-
sion, she developed dry gangrene and necrosis of all limbs
ensued requiring amputation of all the fingers of her right
hand, left wrist disarticulation and open disarticulation of
all her toes.
Eleven weeks after admission, our patient developed
hematochezia from the colostomy associated with a de-
crease in hemoglobin from 11.4g/dL to 6.4g/dL. Our pa-
tient was initially stabilized with continuous intravenous
pantoprazole infusion and received four units of packed
red blood cells. Colonoscopy through the ostomy revealed
blood throughout the colon and a 3cm necrotic ulcer with
an adherent clot in the transverse colon (Figure 1A). Mul-
tiple biopsies were taken from the edge of the colonic
ulcer. Pathological analysis of the specimen (Figure 2A
and 2B) with hematoxylin and eosin (H&E) and Grocott’s
methenamine silver (GMS) stain revealed septated hyphae
with 45-degree-angle branching morphologically consis-
tent with Aspergillus species. Our patient was then im-
mediately treated with intravenous voriconazole, 360mg
every 12 hours for a total of 30 days. One month after the
initial colonoscopy, melena was seen in the ileostomy bag.
An upper endoscopy revealed superficial non-bleeding
erosions in the esophagus and gastric body. A pathological
analysis revealed chronic gastritis and no fungal organisms.
No further bleeding episodes were noted. She continued to
have a complicated hospital course associated with pleural
effusions, sacral decubitus ulcers, and intramuscular
Figure 1 A 3cm necrotic ulcer with an adherent blood clot in
the transverse colon.
Figure 2 (A) Hematoxylin and eosin stain showing fungi micro-
organism amid necrotic debris, blood and fibrin. (B) Grocott's
methenamine silver stain highlighting septated hyphae with 45-degree-
angle branching, morphologically consistent with Aspergillus species.
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follow-up, she was still in the hospital undergoing further
care but had no recurrent gastrointestinal bleeding.
Discussion
Although the lung is the most commonly affected site in
IA, the involvement of other sites, such as the central
nervous system, paranasal sinuses, heart, bones, joints,
eyes, skin, kidneys, and gastrointestinal tract have been
reported [5]. The gastrointestinal tract is the second
most common site of invasive aspergillosis, and the
small intestine is its most affected organ [5,6]. Gastro-
intestinal aspergillosis typically occurs in the settings of
disseminated infection and its frequency in this scenario
is approximately 17% based on several autopsy studies
[5,7,8]. Characteristic features of gastrointestinal asper-
gillosis include invasion of the mesenteric arteries, intra-
vascular thrombosis and subsequent tissue ischemia.
This ischemic lesion leads to infarction and even per-
foration of the intestine. IA of the small bowel has a
typical macroscopic appearance of a thickened and pur-
plish wall with islands of necrotic tissue [8-10].
Clinical manifestations of IA of the gastrointestinal
tract can include fever, abdominal pain, ileus, peritonitis,
bloody diarrhea or hematochezia. Radiographic findings
of diffuse small bowel distention and wall thickening
may aid in the diagnosis [11]. However, there are no spe-
cific radiologic findings that will immediately suggest IA
of the gastrointestinal tract. Common surgical or en-
doscopic findings in previously reported cases include
ulcerative or necrotic lesions.
Most of the literature on gastrointestinal IA comes from
case reports or case series as summarized in Table 1.
Eggiman et al. reported on two cases and reviewed eight
previously published cases in the literature. Nine patients
had a hematologic malignancy with eight of them re-
ceiving cytarabine [3]. This chemotherapeutic agent has a
cytotoxic effect on the colonic mucosa that disrupts the
normal mucosal barriers and allows invasion by Aspergillus
[12]. High doses of cytarabine-induced mucositis can lead
to ulceration and a favorable environment for colonization
by Aspergillus spores [13]. Cohen et al. reported a neutro-
penic patient with acute myelogenous leukemia treated
with cytarabine and idarubicin who presented with fever
and bloody diarrhea secondary to bowel infarction from IA
[9]. However, not all patients had received chemotherapy,
as described in a case by Choi et al. In this case, isolated
IA of the colon was diagnosed in a patient with colon can-
cer who was not receiving chemotherapy [14].
Gastrointestinal IA may be more common than origin-
ally thought. In a series of 107 autopsy reports of patients
with IA [1], 37 had gastrointestinal IA (16 with upper tract
involvement, nine with lower tract involvement, seven
hepatic IA and five pancreatic IA). The two most common
Table 1 Case reports of invasive Aspergillus in the gastrointestinal tract






Karaman et al. [5] Arthrogryposis multiplex
congenita
None Abdominal pain and vomiting Stomach Surgery None.
Eggiman et al. [3] Acute myeloid leukemia
(2 cases)
Cytarabine, idarubicin Fever, bloody diarrhea bleeding,
ileus or peritonitis
Small intestine Surgery Amphotericin B
Cohen et al. [9] Acute myeloid
leukaemia
Cytarabine, daunorubicin Fever, watery diarrhea, peritonitis Small intestine Surgery None. Patient died.
Trésallet et al. [11] Lymphoma Cytarabine, etoposide Fever, peritonitis Small intestine Surgery Voriconazole
Chaudhary et al. [6] Breast carcinoma Cyclophosphamide, adriamycin,
5-fluorouracil
Fever, constipation, abdominal pain Small intestine None Amphotericin B




Fever and diarrhea Colon Surgery Amphotericin B
Choi et al. [14] Colon cancer None Hematochezia Colon Endoscopy Amphotericin B


















Bizet et al. Journal of Medical Case Reports 2014, 8:407 Page 5 of 6
http://www.jmedicalcasereports.com/content/8/1/407pathological findings in these patients included ulcers and
abscesses. Of the 16 patients with upper gastrointestinal
tract involvement, eight were asymptomatic, five had
upper abdominal pain and three had massive melena.
Among the nine with lower gastrointestinal tract involve-
ment, four were asymptomatic, two had hematochezia,
one had a mass in the colon, one had peritonitis and one
had ileus.
The definitive diagnosis of IA requires histopatho-
logical evidence of infection such as direct microscopy
of fluid or tissue specimens showing the characteristic
angular dichotomously branching septated hyphae and
confirmatory culture results [15]. However, if cultures
and microscopy are negative, then the diagnosis relies
on the surrogate non-culture-based method in patients
with compatible clinical manifestations and risk factors
[14]. These non-culture-based methods include galacto-
mannan or (1,3) ß-D-glucan assay. Galactomannan and
(1,3) ß-D-glucan are components of the cell wall of the
Aspergillus mold released during the growth of hyphae
[14]. Galactomannan antigen is detected in body fluids
through an enzyme-linked immunosorbent assay (ELISA).
However, this assay is not specific for the type of Aspergillus
species. The initial therapy for IA includes voriconazole,
but amphotericin B can be used if the patient is unable to
tolerate voriconazole [16,17]. Surgical treatment of gastro-
intestinal aspergillosis is required for complications, such as
perforation, obstruction, bleeding and infarction.
Conclusions
Gastrointestinal aspergillosis is an unusual presentation of
invasive aspergillosis and is associated with a high mor-
tality rate. Due to its low incidence, IA is not routinely
considered as a differential diagnosis of lower gastrointes-
tinal bleeding. However, in the setting of an immunocom-
promised patient secondary to sepsis with gastrointestinal
bleeding found to have necrotic ulcers on endoscopic
examination, IA should be included in the differential
diagnosis.
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